COPD Management in the time of COVID-19 & New Real World Data on Inhaler Choice

Thank you

Thank you for participating in today's webinar.

Expect a brief satisfaction survey via email. Your feedback is appreciated as it helps improve programming for the future.

Description

Boehringer Ingelheim is pleased to bring you a stimulating discussion featuring a panel of experts: Brad Drummond, MD, and Mike Hess RT.

These panelists will review:

What have we learned about COPD management and how can we stay informed amidst the COVID-19 pandemic?

How does real-world evidence (RWE) enhance our knowledge on the prevalence of suboptimal peak inspiratory flow (PIF) in COPD?

In addition, these panelists will review:

Did real world evidence show an association between inhaler choice and exacerbation frequency, and readmissions in the treatment of COPD?

You don’t want to miss the “COPD Management in the time of COVID-19 & New Real World Data on Inhaler Choice” webinar happening at 12PM EST on Tuesday, September 1^st, 2020.

This program is sponsored by Boehringer Ingelheim.

By registering for this webinar, you agree your information will be shared with the sponsor.

No CEU's or credits are provided for this webinar.

Opinions expressed and resources shared may not have been reviewed by the ATS prior to distribution through ATS channels, or reflect official positions of the ATS, unless it is explicitly noted as a result of official ATS approval. References to specific commercial entities (companies) or products do not reflect review or endorsement by the ATS unless it is explicitly noted as a result of official ATS approval.

Contributors

M. Brad Drummond, MD, MHS

Associate Professor of Medicine, Pulmonary Diseases and Critical Care
Director, Obstructive Lung Diseases Clinical and Translational Research Center
University of North Carolina – Chapel Hill

Dr. Drummond is a clinical and translational researcher whose research focus includes characterizing the mechanisms for development of chronic lung disease in individuals at-risk or with chronic obstructive pulmonary disease (COPD). He has expertise in epidemiology and clinical trials design, and has applied these skills to understand the pattern and risk factors for lung function progression in smokers as well as HIV-infected individuals. His primary project is an NHLBI-funded study of a novel biomarker in the blood and lungs of individuals with or at-risk for COPD, and examining the role of vitamin D on levels of this biomarker. Additionally, Dr. Drummond is involved in characterizing the longitudinal impact of smoking, HIV infection and tobacco dependence on long-term outcomes related to chronic obstructive pulmonary disease. He is the director of the UNC Obstructive Lung Diseases Clinical and Translational Research Center.
Michael Hess, RRT, RFTP

Western Michigan University Homer Stryker M.D. School of Medicine

Michael T. Hess, BS, RRT, RPFT is a respiratory therapist and is currently Chronic Lung Disease Coordinator at Western Michigan University Homer Stryker M.D. School of Medicine. After receiving his initial clinical training through Kalamazoo Valley Community College, he completed a bachelor's degree through Western Michigan University's College of Health and Human Services, and is in the process of acquiring a Master of Public Health degree through that institution.

A respiratory therapist for over a decade, Mr. Hess is passionate about respiratory therapy and the role respiratory care practitioners play in optimizing outcomes and improving quality of life. Mr. Hess' passion is improving COPD education, awareness, and management in the outpatient setting. He has focused on treating chronic obstructive pulmonary disease (COPD) for the last several years, and is the project coordinator for WMed's NHLBI COPD Learn More Breathe Better® subcontract in Kalamazoo, MI. The NHLBI's COPD Learn More Breathe Better® program seeks to: Increase awareness of COPD as a serious lung disease and a leading cause of death in the United States; Increase understanding that COPD is treatable; Encourage people at risk to get a simple breathing test and talk to their doctor or health care provider about treatment options. The COPD Learn More Breathe Better program supports the Breathe Better Network, a partnership of organizations around the country working to raise awareness about COPD in their communities.

Mr. Hess is President and member of the Executive Committee of the Michigan Society for Respiratory Care (MSRC). Mr. Hess was recipient of the COPD Foundation's Young Investigator Award in 2015 and the President's Award of the Michigan Society for Respiratory Care (MSRC) in 2009. Mr. Hess has been a frequent presenter at the Michigan Society for Respiratory Care (MSRC) and American Association for Respiratory Care (AARC) Annual Meetings. His presentation topics included: Respiratory Therapy in the Primary Care World; National COPD Action Plan; High Reliability Principles to Maximize Patient Safety, etc. among others. Mr. Hess was also appointed to the U.S. COPD Coalition Board of Directors for a term starting Aug. 1, 2018. Mr. Hess is a member of the American Association for Respiratory Care (AARC). He currently manages a first-of-its-kind COPD clinic in Kalamazoo, Michigan, working to ensure patients get connected with the care they need when they need it.

Thank you

Description

Contributors

M. Brad Drummond, MD, MHS

Michael Hess, RRT, RFTP